Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.
42 U.S.C. 1320f-3 Negotiation and renegotiation process
42 U.S.C. 1320f-3 Negotiation and renegotiation process, “Negotiation and renegotiation process”, is a U.S. Code section of Part E—Price Negotiation Program to Lower Prices for Certain High-Priced Single Source Drugs; in force.
https://ontology.bommaritollc.com/id/01a0f07c-e07e-750e-8424-d81ef2c9ff35
Elsewhere
Facts
| adms:identifier | |
| eli:cites | |
| prov:wasDerivedFrom | |
| schema:isPartOf | |
| schema:legislationIdentifier | 42 U.S.C. 1320f-3 |
| schema:legislationJurisdiction | |
| schema:legislationLegalForce | |
| schema:legislationType | |
| schema:name | Negotiation and renegotiation processen |
| schema:url | |
| skos:prefLabel | 42 U.S.C. 1320f-3 Negotiation and renegotiation processen |
Related
Cited by (7)eli:cites
- 42 U.S.C. 1320f Establishment of program
- 42 U.S.C. 1320f-1 Selection of negotiation-eligible drugs as selected drugs
- 42 U.S.C. 1320f-2 Manufacturer agreements
- 42 U.S.C. 1320f-4 Publication of maximum fair prices
- 42 U.S.C. 1320f-5 Administrative duties and compliance monitoring
- 42 U.S.C. 1320f-7 Limitation on administrative and judicial review
- 42 U.S.C. 1395w-112 Requirements for and contracts with prescription drug plan (PDP) sponsors